KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables - Other (2016)

Historic Receivables - Other for Bausch Health Companies (BHC) over the last 4 years, with Q4 2016 value amounting to $60.0 million.

  • Bausch Health Companies' Receivables - Other changed N/A to $60.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was $60.0 million, marking a year-over-year change of. This contributed to the annual value of $60.0 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bausch Health Companies reported Receivables - Other of $60.0 million as of Q4 2016.
  • Bausch Health Companies' 5-year Receivables - Other high stood at $60.0 million for Q4 2016, and its period low was $12.9 million during Q1 2012.
  • Moreover, its 3-year median value for Receivables - Other was $12.9 million (2012), whereas its average is $18.1 million.
  • Data for Bausch Health Companies' Receivables - Other shows a peak YoY increase of 0.0% (in 2013) and a maximum YoY decrease of 0.0% (in 2013) over the last 5 years.
  • Over the past 3 years, Bausch Health Companies' Receivables - Other (Quarter) stood at $12.9 million in 2012, then changed by 0.0% to $12.9 million in 2013, then skyrocketed by 365.12% to $60.0 million in 2016.
  • Its Receivables - Other stands at $60.0 million for Q4 2016, versus $12.9 million for Q4 2013 and $12.9 million for Q3 2013.